Le diabète non-insulinodépendant : une affection en expansion. Importance d’une approche multidisciplinaire

Bulletin de l'Académie Nationale de Médecine - Tập 187 - Trang 1307-1316 - 2003
Pierre Lefebvre1
1Membre associé étranger de l’Académie nationale de médecine.

Tài liệu tham khảo

Lefebvre, 1988, Clinical forms of diabetes mellitus, 1 Sinha, 2002, Prevalence of impaired glucose tolerance among children and adolescents with marked obesity, N Engl. J. Med, 346, 802, 10.1056/NEJMoa012578 Scheen, 1996, Le diabète non insulinodépendant : de la physiopathologie au traitement, Bulletin et Mémoires de l’Académie royale de Médecine de Belgique, 757, 395 Scheen, 2000, Insulin resistance vs insulin deficiency : which comes first ? The old question revisited, 101 World Health Organization, 2002, The World Health Report 2002. Reducing risks, promoting healthy life, WHO publications Barker, 2001, Type 2 diabetes : the thrifty phenotype, Brit. Med. Bull., 60, 1, 10.1093/bmb/60.1.1 Barker, 1999, Signalisation de l’insuline et mécanismes moléculaires de l’insulinorésistance, Journées de Diabétologie, 125 Lefebvre, 2003, Diabetes prevention and strategic action, IDF Diabetes Atlas, 301 Zimmet, 1997, The global NIDDM epidemic. Treating the disease and ignoring the symptom. Diabetologia, 1996, 39, 1247-1248. Traduction française : Le diabète non insulinodépendant : Une pandémie. Traiter la maladie et ignorer le symptôme, Diabetes & Metabolism (Paris), 23, 448 Hancu, 2002, 286 American Diabetes Association, 2003, Standards of medical care for patients with diabetes mellitus, Diabetes Care, 26, S33, 10.2337/diacare.26.2007.S33 Agence Française De Sécurité Sanitaire Des Produits De Santé, 1999, Traitement médicamenteux du diabète de type 2. Recommandations : texte long, argumentaire, Diab Metab, 25, 1 Scheen, 2000, Treatment of Diabetes Mellitus, 685 Gaede, 2003, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N. Engl. J. Med., 348, 383, 10.1056/NEJMoa021778 Uk Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Uk Prospective Diabetes Study (UKPDS) Group, 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38, BMJ, 317, 703, 10.1136/bmj.317.7160.703 2002, MCR/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals : a randomised placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 Khamaisi, 2003, Thiazolidinediones in cardiovascular risk in type 2 diabetes mellitus, 193 Ravid, 1996, Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: a 7-year follow-up study, Arcli. Intern. Med., 156, 286, 10.1001/archinte.1996.00440030080010 Gaede, 1999, Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria : the Steno type 2 randomised study, Lancet, 353, 617, 10.1016/S0140-6736(98)07368-1 Scheen, 2002, New antiobesity agents in type 2 diabetes : Overview of clinical trials with sibutramine and orlistat, Diabetes Met ab (Paris), 28, 437 Hollander, 1998, Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomised double-blind study, Diab Care, 27, 1288, 10.2337/diacare.21.8.1288 Dailey, 2001, Patient compliance and persistence with antihyperglycemic drug regimens : Evaluation of a Medicaid patient population with type 2 diabetes mellitus, Clinical Therapeutics, 23, 1311, 10.1016/S0149-2918(01)80110-7 Pan, 1997, Effect of diet and exercise in preventing NIDDM in people with impaired glucose tolerance : the Da Quing IGT and Diabetes Study, Diab. Care, 20, 537, 10.2337/diacare.20.4.537 Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N. Engl. J. Med., 344, 1343, 10.1056/NEJM200105033441801 Diabetes Prevention Programme Research Group, 2002, Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin, N. Engl. J. Med., 346, 393, 10.1056/NEJMoa012512 Chiasson, 2002, for the Stop-NiDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus : the STOP-NIDDM randomised trial, Lancet, 359, 2072, 10.1016/S0140-6736(02)08905-5 International Diabetes Federation, 2003, Global Strategic Plan to Raise Awareness of Diabetes, 20